Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Mupirocin Calcium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,244Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal's Generic Mupirocin Calcium Receives Approval in the U.S.
    Amneal's Generic Mupirocin Calcium Receives Approval in the U.S.

    15 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214811

    FDA
    15 Nov 2022
    Share Share
    Padagis Generic Mupirocin Calcium Receives Approval in the U.S.
    Padagis Generic Mupirocin Calcium Receives Approval in the U.S.

    03 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212465

    FDA
    03 Aug 2022
    Share Share
    Aleor Dermaceutical`s Generic Metronidazole Receives Approval in the US
    Aleor Dermaceutical`s Generic Metronidazole Receives Approval in the US

    19 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213053

    FDA
    19 Nov 2021
    Share Share
    GlaxoSmithKline recalls Bactroban (mupirocin calcium) Nasal Ointment, 2% due to Cross Contamination
    GlaxoSmithKline recalls Bactroban (mupirocin calcium) Nasal Ointment, 2% due to Cross Contamination

    05 Sep 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1359-2015&w=09022015&lang=eng

    FDA
    05 Sep 2015
    Share Share